This was followed by the genotypes of IFNL3, which are predicted to produce an unfavorable response to treatment for Hepatitis C in 52.5% of the population studied (Hom alt: 10.4%; Het: 42.2%). Here, IFNL3 is linked to hepatitis C virus infection.